Olympiad Research’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Olympiad Research’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-54,795	Closed	-$1.01M	–	189
2020 Q4	$1.01M	Buy	54,795 +41,311	+306%	+$753K	0.58%	30
2020 Q3	$247K	Buy	+13,484	New	+$227K	0.13%	219

Olympiad Research's CBMG Position: Q1 2021 in Review

Olympiad Research sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 54,795 shares — an estimated $1.01M sold.

Olympiad Research first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $1.01M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Olympiad Research reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Olympiad Research sold 54,795 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.01M.
Olympiad Research first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
Olympiad Research's Cellular Biomedicine Group, Inc. position peaked at $1.01M in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Olympiad Research's 13F filing for Q1 2021, filed 5 May 2021.